Clinica Domani, Belo Horizonte, Brazil.
Bioscor International, Melbourne, Victoria, Australia.
J Cosmet Dermatol. 2023 Dec;22(12):3223-3231. doi: 10.1111/jocd.15969. Epub 2023 Oct 2.
Injectable poly-L-lactic acid (PLLA) has been proven safe and effective with numerous medical applications for more than 25 years. The product has been approved in over 40 countries and is being used for soft tissue augmentation in the face and certain body parts. With the increased demand for subtle and natural-looking aesthetic treatments in the Asia-Pacific region, there is also a heightened need for consistent preparation and effective treatment methodologies to optimize outcomes for Asian patients.
The body of evidence in medical literature, clinical data of presented case reports, and the collective experience of the authors are reflected in these consensus recommendations, which also take under consideration the availability of biostimulators in the Asia-Pacific region.
The resulting consensus recommendations include patient selection and assessment, management of treatment expectations, appropriate preparation and storage, proper injection techniques and treatment plans, management of adverse effects, PLLA combination with other facial rejuvenation procedures, and other constructive considerations.
In the above consensus recommendations, the authors shared their best practices in accordance with the updated preparation and treatment protocols of PLLA. These recommendations represent the clinical and real-world techniques utilized by authors in providing PLLA treatments for Asian patients.
聚左旋乳酸（PLLA）已被证明在超过 25 年的时间里具有安全性和有效性，在许多医学领域都有应用。该产品已在 40 多个国家获得批准，用于面部和某些身体部位的软组织填充。随着亚太地区对微妙、自然审美治疗的需求增加，也需要一致的准备和有效的治疗方法，以优化亚洲患者的治疗效果。
这些共识建议反映了医学文献中的证据、呈现的病例报告的临床数据以及作者的集体经验，同时也考虑到了亚太地区生物刺激剂的可及性。
最终的共识建议包括患者选择和评估、治疗期望的管理、适当的准备和储存、正确的注射技术和治疗计划、不良反应的管理、PLLA 与其他面部年轻化手术的联合应用，以及其他建设性的考虑因素。
在上述共识建议中，作者根据 PLLA 的最新准备和治疗方案分享了他们的最佳实践。这些建议代表了作者在为亚洲患者提供 PLLA 治疗时所采用的临床和实际技术。
